IVZ have the fundamentals with everything in the floor and the...

IVZ have the fundamentals with everything in the floor and the discovery, what they didn’t have was a PPSA which no one on the register knew we actually needed to begin to develop the asset

NYR already have the discovery and studies all the way back from 2004 to 2024 already further support the final outcome. NYR has nothing to do with oil and gas so don’t compare. It’s 3 months away from the first in human phase 1 trials for both stroke and TB and Walter Reed which further de risks the drug outcome. All comparable peers in the same position in a biotechs life cycle trades at a 70-100 million market cap and trading at a 10 million market cap with 10 million in funding is funny